HC Surgical Specialists (SGX:1B1) Beta: 0.4638 (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SGX:1B1 HC Surgical Specialists Ltd SGX:1B1
63 GF Score
Price S$0.35
GF Value S$0.30
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is HC Surgical Specialists Beta?

HC Surgical Specialists SGX:1B1 +1.45% 63 Beta is 0.4638 as of Aug. 25, 2026. GuruFocus rates SGX:1B1 with a GF Score™ of 63/100 and a GF Value™ of S$0.30 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-25), HC Surgical Specialists's Beta is 0.4638.


HC Surgical Specialists  (SGX:1B1) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


HC Surgical Specialists Beta Related Terms


HC Surgical Specialists Beta Historical Data

* Premium members only.

The historical data trend for HC Surgical Specialists's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HC Surgical Specialists Beta Chart

HC Surgical Specialists Annual Data
Trend May17 May18 May19 May20 May21 May22 May23 May24 May25 May26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.60 0.01 0.40 0.74 0.94

HC Surgical Specialists Semi-Annual Data
Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25 May26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.54 0.74 0.92 0.94

SGX:1B1 vs TMO, DHR, IDXX: Beta Comparison

For the Diagnostics & Research subindustry, HC Surgical Specialists's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HC Surgical Specialists Beta vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HC Surgical Specialists's Beta distribution charts can be found below:

* The bar in red indicates where HC Surgical Specialists's Beta falls into.


SGX:1B1
63GF Score
HC Surgical Specialists Ltd SGX:1B1
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HC Surgical Specialists Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.4638 mean?
HC Surgical Specialists (SGX:1B1) has a Beta of 0.4638 as of Aug. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for HC Surgical Specialists and its competitors.
Is HC Surgical Specialists' Beta too high?
HC Surgical Specialists' current Beta is 0.4638. Overall, HC Surgical Specialists has a GF Score™ of 63/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HC Surgical Specialists' Beta compare to TMO and DHR?
HC Surgical Specialists' Beta of 0.4638 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Diagnostics & Research company?
A good Beta depends on the Medical Diagnostics & Research industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for HC Surgical Specialists and its competitors. HC Surgical Specialists's current Beta is 0.4638. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HC Surgical Specialists stock overvalued right now?
Based on GuruFocus' analysis, HC Surgical Specialists (SGX:1B1) is currently considered Modestly Overvalued. The stock's GF Value™ is S$0.30, compared to a current price of S$0.35 — trading 16.7% above its estimated fair value. The current Beta is 0.4638. HC Surgical Specialists' overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For HC Surgical Specialists (SGX:1B1), the current Beta is 0.4638 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HC Surgical Specialists (SGX:1B1) Overvalued in 2026?

Based on GuruFocus' analysis, HC Surgical Specialists stock appears to be overvalued. The current stock price of S$0.35 is trading 16.7% above its estimated GF Value™ of S$0.30. GuruFocus considers HC Surgical Specialists to be Modestly Overvalued.

Key valuation signals for SGX:1B1:

  • Beta: 0.4638
  • GF Value™: S$0.30 vs. price of S$0.35 (16.7% above fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the SGX:1B1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


HC Surgical Specialists Business Description

Address 233 River Valley Road, No. B1-04/05 RV Point, Singapore, SGP, 238291
HC Surgical Specialists Ltd is a medical services group. The company is engaged in providing endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services. The operating segment of the company is the healthcare segment. Geographically, it operates only in Singapore. The company has its facilities center and clinics at various places in Singapore.
63GF Score

Get the complete analysis for SGX:1B1

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.35
Price
S$0.30
GF Value